Providing Continuous Industry Advisory and Support
BiotechCorp remains committed towards providing effective and efficient services to clients to ensure sustained interest in industry growth initiatives and the momentum of implementation of these efforts are maintained.
Focus areas: 1. BioNexus Status
2. Biotechnology Commercialisation Grants 3. Tax Incentives
Key Results:
BioNexus Status
Issue / Activity Results Summary
BiotechCorp processes and evaluates applications from biotechnology companies to award the BioNexus Status.
t"UPUBMOVNCFSPGBQQMJDBUJPOTGPS#JP/FYVT4UBUVTXFSF received by BiotechCorp in 2010. For the year, 39 BioNexus Status companies were approved bringing the total number to 188 (as at December 31, 2010). The companies approved are as follows:
1. BioChemie Science Sdn Bhd 2. Klinsel Sdn Bhd
3. Spektra Biotek Sdn Bhd 4. Bio Marinuus Sdn Bhd 5. Green Alive Sdn Bhd 8BOJUB"OHHVO4EO#IE 7. Ekstrak Tulen Sdn Bhd 8. Phoenix Pharma Sdn Bhd 9. Getz Pharma Sdn Bhd 10. Enretech (M) Sdn Bhd 11. Bio Science R & D Sdn Bhd 12. KLAS Farm Sdn Bhd 13. IOI Palm Biotech Sdn Bhd
14. Astra Diagnostic Asia Pacific Sdn Bhd 15. Medical Biotherapy Sdn Bhd
1BMN0JM8BTUF&OFSHZ4EO#IE
20
No Companies Name
Status Project Initiative Project
Type
This company is involved in designing, building and selling of biogas and recovery plant, which could be extended into steam and power generation.
It has made a total approved investment of RM0.2 million.
Project Secured
Project Secured
Project Secured
Project Secured Oiltek Nova
Bioenergy Sdn Bhd
DDI
21 This company seeks to commercialise natural
product extracts using SFE technology.
It was awarded the BioNexus Status on December 8, 2010 with total approved investment of RM0.2 million.
Avenue Biotech Sdn.
Bhd
DDI
22 This company is involved in the production of
technical-grade ethanol from crude glycerin using the metabolic pathway process.
The Malaysian entity, Glycosbio Asia Sdn Bhd was awarded BioNexus Status on October 28, 2010 with a total approved investment of RM53 million.
Glycos
Biotechnologies Inc
FDI
23 This company is involved in the production of
1,3, propanediol (PDO) at Bio-XCell ecosystem, Nusajaya, Johor, using crude glycerine using metabolic pathway process.
It was awarded with the BioNexus Status in 2009 and has signed a build, lease and transfer agreement with Malaysian Bio-XCell Sdn Bhd for total approved investment of RM133 million.
Metabolic Explorer S. A.
(METEX)
FDI
Next Steps for Industrial Biotechnology:
t Maintain consistency in biogeneric manufacturing in offshore networks/markets and firm up existing CRO/CMO with funds and continuous support from the relevant agencies.
t "UUSBDUNPSFGPSFJHOEJSFDUJOWFTUNFOU '%*UPVTF.BMBZTJBBTBIVCGPSUIFJSJOEVTUSJBM biotechnology activities, particularly multi-national corporations (MNCs).
t 8PSLXJUIMPDBMBHSJDVMUVSFQMBZFSTUPJODSFBTFSFOFXBCMFGFFETUPDLTVQQMZGPSUIF development of industrial biotechnology.
t /VSUVSFMPDBM#JP/FYVTDPNQBOJFTUPFYQBOENBSLFUHMPCBMMZBOEUPJODSFBTFEPNFTUJDEJSFDU investment (DDI).
t 1SPNPUFNPSFMPDBMQMBZFSTUPBEPQU4$'QMBUGPSNUFDIOPMPHZJOUIFJSQSPEVDUJPOUPQSPEVDF high quality and value natural products extracts.
Client Engagement
Providing Continuous Industry Advisory and Support
BiotechCorp remains committed towards providing effective and efficient services to clients to ensure sustained interest in industry growth initiatives and the momentum of implementation of these efforts are maintained.
Focus areas:
1. BioNexus Status
2. Biotechnology Commercialisation Grants 3. Tax Incentives
Key Results:
BioNexus Status
Issue / Activity Results Summary
BiotechCorp processes and evaluates applications from biotechnology companies to award the BioNexus Status.
t"UPUBMOVNCFSPGBQQMJDBUJPOTGPS#JP/FYVT4UBUVTXFSF received by BiotechCorp in 2010. For the year, 39 BioNexus Status companies were approved bringing the total number to 188 (as at December 31, 2010). The companies approved are as follows:
1. BioChemie Science Sdn Bhd 2. Klinsel Sdn Bhd
3. Spektra Biotek Sdn Bhd 4. Bio Marinuus Sdn Bhd 5. Green Alive Sdn Bhd 8BOJUB"OHHVO4EO#IE 7. Ekstrak Tulen Sdn Bhd 8. Phoenix Pharma Sdn Bhd 9. Getz Pharma Sdn Bhd 10. Enretech (M) Sdn Bhd 11. Bio Science R & D Sdn Bhd 12. KLAS Farm Sdn Bhd 13. IOI Palm Biotech Sdn Bhd
14. Astra Diagnostic Asia Pacific Sdn Bhd 15. Medical Biotherapy Sdn Bhd
1BMN0JM8BTUF&OFSHZ4EO#IE
BioNexus Status
Issue / Activity Results Summary
24. BAM Probiotic Sdn Bhd 25. Veras Research Sdn Bhd 26. Fasclone (M) Sdn Bhd 27. Inspisegar Sdn Bhd
28. Sciencegates Biotech Sdn Bhd 29. Sengenics Sdn Bhd
30. Avenue Biotech Sdn Bhd
31. Agro Science Resources Sdn Bhd 32. AsiaBioZymeScience Sdn Bhd 33. Celltis Sdn Bhd
34. Mushroom Ambra Sdn Bhd 35. MCI Bio-Peptide Sdn Bhd 36. SP Aquaculture Sdn Bhd 37. One Bio Sdn Bhd 38. Bioremeds (M) Sdn Bhd
39. JEFI AquaTech Resources Sdn Bhd
t*OBEEJUJPOBQQMJDBUJPOTSFRVFTUJOHDIBOHFTPOTQFDJBMDPOEJUJPOT imposed on BioNexus Status companies were assessed and tabled for the consideration of the BioNexus Evaluation Committee (BEC) and recommended to the Ministry of Finance (MOF).
Biotechnology Commercialisation Grants
Access to early financing is vital to start-up companies commercialising their products and services. Biotechnology Commercialisation Grants IBWFCFOFGJUFEBOVNCFSPG#JP/FYVT4UBUVTDPNQBOJFTFTQFDJBMMZBU the early stage of operations.
t*OBUPUBMPG#JP/FYVT4UBUVTDPNQBOJFTSFDFJWFEHSBOUT VOEFSUIF4FFE3FTFBSDIBOE%FWFMPQNFOUBOE*OUFSOBUJPOBM
#VTJOFTT%FWFMPQNFOUGVOETDIFNFTCSJOHJOHUIFUPUBMOVNCFSPG HSBOUSFDJQJFOUUPDPNQBOJFT BTBU%FDFNCFS5IF grant recipients in 2010 are as follows:
1. Aning Biotech Corporation Sdn Bhd 2. Bio Photonic Healthcare Sdn Bhd 3. Biosmart Sdn Bhd
#JPTBGF.JDSPCF%FWFMPQNFOU$FOUSF4EO#IE 5. Cytopro Malaysia Sdn Bhd
%FMQIBY4EO#IE
%/"3FTFBSDI$FOUSF .4EO#IE (FOFOFXT%JBHOPTUJDT4EO#IE 9. GT Bioscience Sdn Bhd
10. Joint Implants International Sdn Bhd 11. Manna Biotech Sdn Bhd
12. MyCRO Sdn Bhd 13. Myenzyme Sdn Bhd 14. Neopeutics Sdn Bhd
15. North Borneo Herbal Biotechnology Sdn Bhd
Next Steps for Client Services:
t Take on a continuous process enhancement exercise to meet the challenges of Phase 2 of National Biotechnology Policy
t 3PMMPVUPGUIF#JPUFDIOPMPHZ$PNNFSDJBMJTBUJPO'VOEJOH #$'QSPHSBNNFVOEFSUIF3., 10 program
t 1SPWJEFWBMVFBEEFETVQQPSUBOETFSWJDFTXIJDIXJMMDPOUSJCVUFUPXBSETUIFDPNQFUJUJWFOFTT of the BioNexus Status companies.
Issue / Activity Results Summary
Tax Advisory & Services
BiotechCorp processes and evaluates applications for income tax exemptions for BioNexus Status companies and other relevant tax incentives for the industry.
t"QBSUGSPNUIFJODPNFUBYFYFNQUJPOPOTUBUVUPSZJODPNF JODFOUJWFHSBOUFEUP#JP/FYVT4UBUVTDPNQBOJFTBUPUBMPG applications for other BioNexus Status tax incentives were received and processed in 2010. The 12 applications received and
processed for other BioNexus Status tax incentives are: Biotechnology
Commercialisation Grants
16. O3 Solutions Sdn Bhd 17. Pomer Sdn Bhd
18. Promise Earth (M) Sdn Bhd 19. Return 2 Green Sdn Bhd 20. Stella Gen Sdn Bhd
21. World Aquatic Ecosystem Sdn Bhd
1. Genting Plantation Berhad 2. IOI Corporation Berhad
3. BioAlpha International Sdn Bhd 4. Chua Tongsan Sdn Bhd 5. PureCircle Sdn Bhd 6. Stemlife Berhad
7. Genting Green Tech Sdn Bhd 8. TSH Biotech Sdn Bhd 9. IOI Palm Biotech Sdn Bhd
10. Mushroom Ambra Biotech Sdn Bhd 11. SP Aquaculture Sdn Bhd
12. M-Gen-Propagation Sdn Bhd
t*OPVSFGGPSUUPDSFBUFBXBSFOFTTPOUIFCFOFGJUTBOEBEWBOUBHFTPG UBYJODFOUJWFTBDDPSEFEUPDPNQBOJFTXJUIUIF#JPOFYVT4UBUVTUXP seminars were conducted in 2010 including “Seminar on Guidelines on Tax Incentives Accorded to the BioNexus Status Companies” and i4FNJOBSPO*NQPSU%VUZ4BMFT5BY&YFNQUJPOBOE.BMBZTJBO Custom Import/Export Legislation & Procedures”.
BioNexus Status
Issue / Activity Results Summary
24. BAM Probiotic Sdn Bhd 25. Veras Research Sdn Bhd 26. Fasclone (M) Sdn Bhd 27. Inspisegar Sdn Bhd
28. Sciencegates Biotech Sdn Bhd 29. Sengenics Sdn Bhd
30. Avenue Biotech Sdn Bhd
31. Agro Science Resources Sdn Bhd 32. AsiaBioZymeScience Sdn Bhd 33. Celltis Sdn Bhd
34. Mushroom Ambra Sdn Bhd 35. MCI Bio-Peptide Sdn Bhd 36. SP Aquaculture Sdn Bhd 37. One Bio Sdn Bhd 38. Bioremeds (M) Sdn Bhd
39. JEFI AquaTech Resources Sdn Bhd
t*OBEEJUJPOBQQMJDBUJPOTSFRVFTUJOHDIBOHFTPOTQFDJBMDPOEJUJPOT imposed on BioNexus Status companies were assessed and tabled for the consideration of the BioNexus Evaluation Committee (BEC) and recommended to the Ministry of Finance (MOF).
Biotechnology Commercialisation Grants
Access to early financing is vital to start-up companies commercialising their products and services. Biotechnology Commercialisation Grants IBWFCFOFGJUFEBOVNCFSPG#JP/FYVT4UBUVTDPNQBOJFTFTQFDJBMMZBU the early stage of operations.
t*OBUPUBMPG#JP/FYVT4UBUVTDPNQBOJFTSFDFJWFEHSBOUT VOEFSUIF4FFE3FTFBSDIBOE%FWFMPQNFOUBOE*OUFSOBUJPOBM
#VTJOFTT%FWFMPQNFOUGVOETDIFNFTCSJOHJOHUIFUPUBMOVNCFSPG HSBOUSFDJQJFOUUPDPNQBOJFT BTBU%FDFNCFS5IF grant recipients in 2010 are as follows:
1. Aning Biotech Corporation Sdn Bhd 2. Bio Photonic Healthcare Sdn Bhd 3. Biosmart Sdn Bhd
#JPTBGF.JDSPCF%FWFMPQNFOU$FOUSF4EO#IE 5. Cytopro Malaysia Sdn Bhd
%FMQIBY4EO#IE
%/"3FTFBSDI$FOUSF .4EO#IE (FOFOFXT%JBHOPTUJDT4EO#IE 9. GT Bioscience Sdn Bhd
10. Joint Implants International Sdn Bhd 11. Manna Biotech Sdn Bhd
12. MyCRO Sdn Bhd 13. Myenzyme Sdn Bhd 14. Neopeutics Sdn Bhd
Next Steps for Client Services:
t Take on a continuous process enhancement exercise to meet the challenges of Phase 2 of National Biotechnology Policy
t 3PMMPVUPGUIF#JPUFDIOPMPHZ$PNNFSDJBMJTBUJPO'VOEJOH #$'QSPHSBNNFVOEFSUIF3., 10 program
t 1SPWJEFWBMVFBEEFETVQQPSUBOETFSWJDFTXIJDIXJMMDPOUSJCVUFUPXBSETUIFDPNQFUJUJWFOFTT Issue / Activity Results Summary
Tax Advisory &
Services
BiotechCorp processes and evaluates applications for income tax exemptions for BioNexus Status companies and other relevant tax incentives for the industry.
t"QBSUGSPNUIFJODPNFUBYFYFNQUJPOPOTUBUVUPSZJODPNF JODFOUJWFHSBOUFEUP#JP/FYVT4UBUVTDPNQBOJFTBUPUBMPG applications for other BioNexus Status tax incentives were received and processed in 2010. The 12 applications received and
processed for other BioNexus Status tax incentives are:
Biotechnology Commercialisation Grants
16. O3 Solutions Sdn Bhd 17. Pomer Sdn Bhd
18. Promise Earth (M) Sdn Bhd 19. Return 2 Green Sdn Bhd 20. Stella Gen Sdn Bhd
21. World Aquatic Ecosystem Sdn Bhd
1. Genting Plantation Berhad 2. IOI Corporation Berhad
3. BioAlpha International Sdn Bhd 4. Chua Tongsan Sdn Bhd 5. PureCircle Sdn Bhd 6. Stemlife Berhad
7. Genting Green Tech Sdn Bhd 8. TSH Biotech Sdn Bhd 9. IOI Palm Biotech Sdn Bhd
10. Mushroom Ambra Biotech Sdn Bhd 11. SP Aquaculture Sdn Bhd
12. M-Gen-Propagation Sdn Bhd
t*OPVSFGGPSUUPDSFBUFBXBSFOFTTPOUIFCFOFGJUTBOEBEWBOUBHFTPG UBYJODFOUJWFTBDDPSEFEUPDPNQBOJFTXJUIUIF#JPOFYVT4UBUVTUXP seminars were conducted in 2010 including “Seminar on Guidelines on Tax Incentives Accorded to the BioNexus Status Companies” and i4FNJOBSPO*NQPSU%VUZ4BMFT5BY&YFNQUJPOBOE.BMBZTJBO Custom Import/Export Legislation & Procedures”.
Next Steps for Client Services:
t 5BLFPOBDPOUJOVPVTQSPDFTTFOIBODFNFOUFYFSDJTFUPNFFUUIFDIBMMFOHFTPG1IBTFPG /BUJPOBM#JPUFDIOPMPHZ1PMJDZ
t 3PMMPVUPGUIF#JPUFDIOPMPHZ$PNNFSDJBMJTBUJPO'VOEJOH #$'QSPHSBNNFVOEFSUIF3., QSPHSBN
t 1SPWJEFWBMVFBEEFETVQQPSUBOETFSWJDFTXIJDIXJMMDPOUSJCVUFUPXBSETUIFDPNQFUJUJWFOFTT PGUIF#JP/FYVT4UBUVTDPNQBOJFT
Issue / Activity Results Summary
5BY"EWJTPSZ 4FSWJDFT
#JPUFDI$PSQQSPDFTTFTBOEFWBMVBUFTBQQMJDBUJPOTGPSJODPNFUBY FYFNQUJPOTGPS#JP/FYVTTUBUVTDPNQBOJFTBOEPUIFSSFMFWBOUUBY JODFOUJWFTGPSUIFJOEVTUSZ
t"QBSUGSPNUIFJODPNFUBYFYFNQUJPOPOTUBUVUPSZJODPNF JODFOUJWFHSBOUFEUP#JP/FYVT4UBUVTDPNQBOJFTBUPUBMPG BQQMJDBUJPOTGPSPUIFS#JP/FYVT4UBUVTUBYJODFOUJWFTXFSFSFDFJWFE BOEQSPDFTTFEJO5IFBQQMJDBUJPOTSFDFJWFEBOE
QSPDFTTFEGPSPUIFS#JP/FYVT4UBUVTUBYJODFOUJWFTBSF
#JPUFDIOPMPHZ
$PNNFSDJBMJTBUJPO (SBOUT
(FOFOFXT%JBHOPTUJDT4EO#IE (5#JPTDJFODF4EO#IE
+PJOU*NQMBOUT*OUFSOBUJPOBM4EO#IE .BOOB#JPUFDI4EO#IE
.Z$304EO#IE .ZFO[ZNF4EO#IE /FPQFVUJDT4EO#IE
/PSUI#PSOFP)FSCBM#JPUFDIOPMPHZ4EO#IE 04PMVUJPOT4EO#IE
1PNFS4EO#IE
1SPNJTF&BSUI .4EO#IE 3FUVSO(SFFO4EO#IE 4UFMMB(FO4EO#IE
8PSME"RVBUJD&DPTZTUFN4EO#IE
(FOUJOH1MBOUBUJPO#FSIBE
*0*$PSQPSBUJPO#FSIBE
#JP"MQIB*OUFSOBUJPOBM4EO#IE
$IVB5POHTBO4EO#IE 1VSF$JSDMF4EO#IE 4UFNMJGF#FSIBE
(FOUJOH(SFFO5FDI4EO#IE 54)#JPUFDI4EO#IE
*0*1BMN#JPUFDI4EO#IE
.VTISPPN"NCSB#JPUFDI4EO#IE 41"RVBDVMUVSF4EO#IE
.(FO1SPQBHBUJPO4EO#IE
t*ODPOUJOVJOHFGGPSUTUPDSFBUFBXBSFOFTTPGUIFCFOFGJUTBOEBEWBOUBHFT PG#JP/FYVT4UBUVTJODFOUJWFTUXPTFNJOBSTXFSFDPOEVDUFEJO JODMVEJOHi4FNJOBSPO(VJEFMJOFTPO5BY*ODFOUJWFT"DDPSEFEUPUIF
#JP/FYVT4UBUVT$PNQBOJFTwBOEi4FNJOBSPO*NQPSU%VUZ4BMFT5BY
&YFNQUJPOBOE.BMBZTJBO$VTUPN*NQPSU&YQPSU-FHJTMBUJPO 1SPDFEVSFTw